Structurally, Jazz Pharmaceuticals and W. R. Berkley are closely matched — neither holds a meaningful edge overall. W. R. Berkley still leads on profitability and stability, which keeps the comparison from looking entirely one-sided. On the market side, Jazz Pharmaceuticals is in better shape — its trend is intact while W. R. Berkley's trend has broken down.
The comparison is based on similar long-term financial trajectories, not sector labels.
On growth, the clearer edge sits with Jazz Pharmaceuticals plc, while the broader score remains level.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The match is driven mainly by investment intensity and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.
Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.
Earnings growth is one contributing factor within the growth lead.
Capital efficiency also runs the other way, with a 24.4-point ROIC edge acting as a real counterforce.
Growth is the clearest driver of the lead, with profitability adding further support — though profitability still provides a real counterweight.
Break down the JAZZ vs WRB comparison across all dimensions with the full interactive tool.
Explore how JAZZ and WRB each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.